Calamos Advisors LLC boosted its stake in shares of Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 11.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 49,138 shares of the basic materials company’s stock after buying an additional 5,006 shares during the period. Calamos Advisors LLC’s holdings in Cameco were worth $4,496,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Financial Consulate Inc. purchased a new stake in shares of Cameco during the 3rd quarter worth $25,000. Nisa Investment Advisors LLC purchased a new position in Cameco in the fourth quarter valued at about $25,000. Founders Capital Management bought a new position in Cameco in the fourth quarter worth about $27,000. Strategic Advocates LLC bought a new position in Cameco in the third quarter worth about $28,000. Finally, Sunbelt Securities Inc. lifted its position in shares of Cameco by 928.6% during the third quarter. Sunbelt Securities Inc. now owns 360 shares of the basic materials company’s stock valued at $30,000 after buying an additional 325 shares during the last quarter. Institutional investors own 70.21% of the company’s stock.
Cameco Stock Up 0.1%
CCJ stock opened at $122.26 on Monday. The firm has a 50 day moving average of $114.65 and a 200 day moving average of $104.54. The stock has a market capitalization of $53.25 billion, a PE ratio of 126.05, a price-to-earnings-growth ratio of 2.26 and a beta of 1.02. The company has a quick ratio of 1.68, a current ratio of 2.47 and a debt-to-equity ratio of 0.14. Cameco Corporation has a 52 week low of $43.21 and a 52 week high of $135.24.
Analysts Set New Price Targets
CCJ has been the topic of a number of recent analyst reports. TD Securities cut shares of Cameco from a “strong-buy” rating to a “hold” rating in a report on Thursday, March 26th. The Goldman Sachs Group reiterated a “buy” rating and set a $131.00 price objective on shares of Cameco in a research note on Wednesday, February 4th. Weiss Ratings raised shares of Cameco from a “hold (c)” rating to a “buy (b-)” rating in a research report on Monday, February 23rd. William Blair assumed coverage on shares of Cameco in a report on Monday, April 20th. They issued an “outperform” rating on the stock. Finally, Glj Research reaffirmed a “buy” rating and set a $171.20 price target (up from $100.00) on shares of Cameco in a research report on Wednesday, February 18th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $150.40.
Check Out Our Latest Research Report on CCJ
About Cameco
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Recommended Stories
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
